Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Hikma vice chair invests, Kier executives offload shares
(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday. Hikma said executive vice chairman Mazen Darwazah purchased 14,000 shares in the company at a price of 1,603p each, for a total consideration of about £224,418.
The transaction took place on 16 September on the London Stock Exchange.
Separately, Kier said two senior executives sold a combined 600,000 shares the same day.
Chief financial officer Simon Kesterton disposed of 350,000 shares at 203.95p apiece, raising around £713,825.
Group managing director for transportation Giuseppe Incutti meanwhile sold 125,000 shares at 209.51p, 67,500 at 202.79p, and 57,500 at 205.01p, for a total of approximately £516,653.
At 1429 BST, shares in Hikma Pharmaceuticals were up 0.37% at 1,622p, while those in Kier Group were ahead 1.46% at 208.5p.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Mazen Amount purchased: 14,000 @ 1,603.00p Value: £224,420.01
Empire Metals Limited Npv (di) (EEE) Director name: Bunn,Shaun Amount purchased: 40,000 @ 36.50p Value: £14,600.00
Sthree (STEM) Director name: Lehne,Timo Amount purchased: 7,404 @ 139.00p Value: £10,291.56
Eden Research (EDEN) Director name: M. Smith,Sean Amount purchased: 390,624 @ 2.56p Value: £9,999.97
Eden Research (EDEN) Director name: Abrey,Alexander John Amount purchased: 360,490 @ 2.77p Value: £9,985.57
Revolution Beauty Group (REVB) Director name: McDonald,Iain Amount purchased: 333,334 @ 2.95p Value: £9,833.35
Top Director Sells
Kier Group (KIE) Director name: Kesterton,Simon Amount sold: 350,000 @ 203.95p Value: £713,825.00
Bango (BGO) Director name: Anderson, Ray Amount sold: 32,500 @ 101.30p Value: £32,922.50
Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 10,357 @ 40.60p Value: £4,204.94
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
